Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing (original) (raw)
Related papers
Returns on Research and Development for 1990s New Drug Introductions
PharmacoEconomics, 2002
Innovation in the pharmaceutical industry: New estimates of R&D costs
Journal of Health Economics, 2016
Drug Development and the Cost of Capital
Optimization of Pharmaceutical R&D Programs and Portfolios, 2014
The Price of Innovation: New Estimates of Drug Development Costs
Journal of Health Economics, 2003
Pharmaceutical research and development: what do we get for all that money
The Dynamics of Pharmaceutical Regulation and R&D Investments
Journal of Public Economic Theory, 2016
Cost of innovation in the pharmaceutical industry
Journal of Health Economics, 1991
The cost of biopharmaceutical R&D: is biotech different?
Managerial and Decision Economics, 2007
Financial Aspects and the Future of the Pharmaceutical Industry in the United States of America.
Izet Masic, MD, PhD, FWAAS, FEASA, FIAHSI, FEFMI, FACMI
Materia Socio Medica , 2013
The Cost of Pharmaceutical R&D: Is Biotech Different?
2007
Patents and Other Incentives for Pharmaceutical Innovation
Encyclopedia of Health Economics, 2014
Biopharmaceutical Innovation The Roles Of Patents And Research And Development Incentives In
2015
Adaptive licensing: taking the next step in the evolution of drug approval
Clinical pharmacology and therapeutics, 2012
Creating alternative incentives for pharmaceutical innovation
Clinical Therapeutics, 2006
The Future of Pharmaceutical Innovation: New Challenges and Opportunities
The roles of patents and research and development incentives in biopharmaceutical innovation
Health affairs (Project Hope), 2015
Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009
Clinical pharmacology and therapeutics, 2011
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs*
INTERNATIONAL JOURNAL OF HEALTH SCIENCES (IJHS)
Revista Terceiro Incluído, 2024
The European Journal of Health Economics, 2011
Measuring the Pace of New Drug Development in the User Fee ERA
Drug Information Journal, 2000
Patents and New Product Development in the Pharmaceutical and Biotechnology Industries
Submission to the Commission on Intellectual …, 2004
A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness
Health Policy, 2011
The Nature and the Extent of the Market for Technology in Biopharmaceuticals
R&D, Innovation and Competitiveness in the European Chemical Industry, 2004
The Determinants of Pharmaceutical Research and Development Investments
Contributions in Economic Analysis & Policy, 2006
The search for new drugs: a theory of R&D in the pharmaceutical industry
Journal of Economic Studies, 2017
Health Economics Review
Commentary to "Patients not patents: drug research and development as a public enterprise
European journal of clinical investigation, 2017
Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals
Journal of Marketing, 2003
Profitability and drug discovery
Industrial and Corporate Change, 2022
The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?
Journal of Pharmaceutical Marketing & Management, 2003
Drug Development Research, 1995
The Economics of Drug Discovery and the Ultimate Valuation of Pharmacotherapies in the Marketplace
Josephine Sollano, M. Chambers
Clinical Pharmacology & Therapeutics, 2008
UK bio pharma : Innovation re invention and capital at risk
2011